XCYTE THERAPIES INC·4

Dec 13, 7:46 PM ET

FROHLICH MARK 4

4 · XCYTE THERAPIES INC · Filed Dec 13, 2004

Insider Transaction Report

Form 4
Period: 2004-12-09
FROHLICH MARK
Medical Director and VP
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2004-12-09$2.14/sh+20,000$42,80020,000 total
    Exercise: $2.14Exp: 2014-12-09Common (20,000 underlying)
Footnotes (1)
  • [F1]1/60th of total number of shares vest monthly for 36 months and 1/30th of the option shares vest monthly thereafter untill all shares are fully vested.

Documents

1 file
  • 4
    fro15.xmlPrimary